Overview of the PIONEER Clinical Trial Program for Oral Semaglutide

Results from the PIONEER clinical trials program indicate that the first oral glucagon-like peptide-1 receptor agonist (GLP-1RA), oral semaglutide, provides effective glycemic control across a range of different patient populations.

Click PLAY to watch the video abstract.


Click here to watch the full supplement infographic.


Click here to read full article to this video abstract.